전문 번역가, 번역 회사, 웹 페이지 및 자유롭게 사용할 수 있는 번역 저장소 등을 활용합니다.
urotheel
urothelium
마지막 업데이트: 2014-12-09
사용 빈도: 9
품질:
경고: 이 정렬은 잘못되었을 수 있습니다.
잘못된 경우 삭제해 주십시오.
urotheel carcinoom van de blaas
transitional cell carcinoma of bladder
마지막 업데이트: 2014-12-09
사용 빈도: 7
품질:
경고: 이 정렬은 잘못되었을 수 있습니다.
잘못된 경우 삭제해 주십시오.
urotheel carcinoom van de blaas stadium ii
stage ii bladder urothelial carcinoma
마지막 업데이트: 2014-12-09
사용 빈도: 1
품질:
경고: 이 정렬은 잘못되었을 수 있습니다.
잘못된 경우 삭제해 주십시오.
urotheel carcinoom van de blaas stadium 0, met carcinoom in situ
urothelial carcinoma bladder stage 0, with cancer in situ
마지막 업데이트: 2014-12-09
사용 빈도: 1
품질:
경고: 이 정렬은 잘못되었을 수 있습니다.
잘못된 경우 삭제해 주십시오.
urotheel carcinoom van de blaas stadium 0, zonder carcinoom in situ
urothelial carcinoma bladder stage 0, without cancer in situ
마지막 업데이트: 2014-12-09
사용 빈도: 1
품질:
경고: 이 정렬은 잘못되었을 수 있습니다.
잘못된 경우 삭제해 주십시오.
urotheel carcinoom van de blaas stadium i, zonder carcinoom in situ
urothelial carcinoma bladder stage i, without cancer in situ
마지막 업데이트: 2014-12-09
사용 빈도: 1
품질:
경고: 이 정렬은 잘못되었을 수 있습니다.
잘못된 경우 삭제해 주십시오.
tabel 4 bijwerkingen waargenomen bij patiënten met transitioneel cel carcinoom van het urotheel behandeld met vinflunine
table 4 adverse reactions observed in patients with transitional cell carcinoma of the urothelium treated with vinflunine
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
in hogere doses of bij een langere behandelingsduur trad ook vacuolisatie van het urotheel in de blaas op.
at higher doses or longer treatment durations, vacuolisation of the urothelium in the bladder also occurred.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
in een hoofdonderzoek met 370 volwassenen met gevorderd of gemetastaseerd overgangscelcarcinoom van het urotheel werden patiënten die met javlor werden behandeld vergeleken met patiënten die geen antikankermiddel kregen.
in one main study of 370 adults with advanced or metastatic transitional cell carcinoma of the urothelial tract, patients who were given javlor treatment were compared with patients who were not given any anticancer medicine.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
eén fase iii- en twee fase ii-onderzoeken ondersteunen het gebruik van javlor voor de behandeling van gevorderd of gemetastaseerd transitioneel celcarcinoom van het urotheel als tweedelijnsbehandeling na het falen van een eerdere behandeling met platinumhoudende middelen.
one phase iii and two phase ii trials support the use of javlor for treatment of advanced or metastatic transitional cell carcinoma of the urothelium as second-line therapy after failure of a prior platinum- containing regimen.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
bijwerkingen die voorkomen bij patiënten met transitioneel celcarcinoom van het urotheel en bij patiënten met een andere ziekte dan deze indicatie en potentieel ernstige reacties of bijwerkingen die een klasse-effect zijn van de vinca-alkaloïden worden hieronder beschreven:
adverse reactions occurring in patients with transitional cell carcinoma of the urothelium and in patients with other disease than this indication and potentially severe or adverse reactions that are a class effect of the vinca alkaloids are described below:
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질: